BENEFITS

There are many groups and individuals who are benefiting from this government initiative:

UK Biotech companies, academic and charitable drug discovery groups have their abilities to bring new medicines to market enhanced, through the use of the NBC’s guiding expertise and state-of-the-art facilities.

Patients can benefit from the accelerated development of new, life-saving medicines.

The Merseyside region will enjoy long-term prosperity from a sharper focus on cutting edge biopharmaceutical manufacturing technology.

And, last but not least,

The UK Biotech Industry as a whole will have increased capability to commercialise UK bioscience discoveries, which in turn will enhance the UK’s international competitiveness.